| 1 |
35482061 | Effect of bisphosphonates on selected markers of bone turnover in patients after total knee arthroplasty. | 2022 Jul |
1 |
| 2 |
34166796 | Juvenile Paget's Disease: Report of a successful treatment throughout the complete growth of a patient with a missense TNFRSF11B mutation. | 2021 Dec |
1 |
| 3 |
34279472 | Comparison of the Effect of Oral Versus Intravenous Bisphosphonate Administration on Osteoclastogenesis in Advanced-Stage Medication-Related Osteonecrosis of the Jaw Patients. | 2021 Jul 4 |
1 |
| 4 |
32276287 | Bisphosphonates inhibit surface-mediated osteogenesis. | 2020 Aug 1 |
1 |
| 5 |
33374546 | Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model. | 2020 Dec 23 |
4 |
| 6 |
28367895 | Effect of bisphosphonate as an adjunct treatment for chronic periodontitis on gingival crevicuar fluid levels of nuclear factor-κB ligand (RANKL) and osteoprotegerin in postmenopausal osteoporosis. | 2017 |
1 |
| 7 |
28534161 | Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational Study. | 2017 Oct |
1 |
| 8 |
28809381 | Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis? | 2017 Sep 1 |
1 |
| 9 |
25055746 | Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts. | 2015 Apr |
1 |
| 10 |
26614482 | The effect of bisphosphonate treatment on the biochemical and cellular events during bone remodelling in response to microinjury stimulation. | 2015 Nov 27 |
1 |
| 11 |
24373581 | Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells. | 2014 Jan |
2 |
| 12 |
23607938 | Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. | 2013 Aug |
1 |
| 13 |
20938793 | Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. | 2012 Feb |
5 |
| 14 |
19574937 | Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis. | 2010 Jan-Feb |
1 |
| 15 |
19577359 | Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. | 2010 Jan 1 |
2 |
| 16 |
16435076 | Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients. | 2006 |
8 |
| 17 |
16101188 | Bisphosphonate treatment does not affect serum levels of osteoprotegerin and RANKL in hypercalcemic cancer patients. | 2005 Sep-Oct |
1 |
| 18 |
14753746 | The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). | 2004 Jan |
2 |
| 19 |
12632438 | Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. | 2003 Mar |
1 |
| 20 |
12732166 | Aetiology of bone disease and the role of bisphosphonates in multiple myeloma. | 2003 May |
1 |
| 21 |
12916277 | [Osteoprotegerin/RANKL/RANK system and postmenopausal osteoporosis. The possible therapeutic aspects]. | 2003 Apr |
1 |
| 22 |
11855844 | Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. | 2002 Mar 1 |
5 |
| 23 |
12562045 | Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis. | 2002 Dec |
1 |